Innovent Biologics
PulseAugur coverage of Innovent Biologics — every cluster mentioning Innovent Biologics across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Chinese funds boost Hong Kong biotech investments amid sector rally
Mainland Chinese investment funds are increasing their stakes in Hong Kong-listed biotechnology companies, attracted by what analysts describe as attractive valuations and relatively low stock prices. E Fund Management …
-
Ningbo Yun Sheng seeks HK listing; Innovent licenses DMX-200
Ningbo Yun Sheng has submitted an application to the Hong Kong Stock Exchange for an H-share issuance and listing. Separately, Innovent Biologics has entered into an exclusive licensing agreement with Dimerix Limited to…
-
Innovent Biologics partners with Pfizer in US$10.5B cancer drug deal
Innovent Biologics has entered into a significant collaboration with Pfizer, valued at up to US$10.5 billion, to advance 12 cancer drug programs. The deal includes an upfront payment of US$650 million to Innovent, with …
-
Innovent Biologics and Bristol Myers Squibb partner on 13 early-stage drug projects
Innovent Biologics has entered into a global strategic collaboration and licensing agreement with Bristol Myers Squibb to advance 13 early-stage projects across oncology, hematology, and immunology. This partnership aim…